Francesco Briganti1, Giuseppe Leone2, Lorenzo Ugga2, Mariano Marseglia3, Domenico Solari4, Ferdinando Caranci2, Giuseppe Mariniello4, Francesco Maiuri4, Paolo Cappabianca4. 1. Department of Advanced Biomedical Sciences, Unit of Interventional Neuroradiology, "Federico II" University, Via S. Pansini, 5, 80131, Naples, Italy. frabriga@unina.it. 2. Department of Advanced Biomedical Sciences, "Federico II", Via S. Pansini, 5, 80131, Naples, Italy. 3. Department of Advanced Biomedical Sciences, Unit of Interventional Neuroradiology, "Federico II" University, Via S. Pansini, 5, 80131, Naples, Italy. 4. Division of Neurosurgery, Department of Neurosciences, Reproductive and Odontostomatological Sciences, "Federico II" University, Via S. Pansini, 5, 80131, Naples, Italy.
Abstract
BACKGROUND: Experience with the endovascular treatment of cerebral aneurysms by the Flow Re-Direction Endoluminal Device (FRED) is still limited. The aim of this study is to discuss the results and complications of this new flow diverter device (FDD). METHODS: Between November 2013 and April 2015, 20 patients (15 female and five male) harboring 24 cerebral aneurysms were treated with FRED FDD in a single center. RESULTS: Complete occlusion was obtained in 20/24 aneurysms (83 %) and partial occlusion in four (17 %). Intraprocedural technical complication occurred in one case (4 %) and post-procedural complications in three (12 %). None reported neurological deficits (mRS = 0). All FRED were patent at follow-up. No early or delayed aneurysm rupture, no subarachnoid (SAH) or intraparenchymal hemorrhage (IPH) no ischemic complications and no deaths occurred. CONCLUSIONS: Endovascular treatment with FRED FDD is a safe treatment for unruptured cerebral aneurysms, resulting in a high rate of occlusion. The FRED is substantially equivalent to the other known FDDs, which show similar functions and technical profiles.
BACKGROUND: Experience with the endovascular treatment of cerebral aneurysms by the Flow Re-Direction Endoluminal Device (FRED) is still limited. The aim of this study is to discuss the results and complications of this new flow diverter device (FDD). METHODS: Between November 2013 and April 2015, 20 patients (15 female and five male) harboring 24 cerebral aneurysms were treated with FRED FDD in a single center. RESULTS: Complete occlusion was obtained in 20/24 aneurysms (83 %) and partial occlusion in four (17 %). Intraprocedural technical complication occurred in one case (4 %) and post-procedural complications in three (12 %). None reported neurological deficits (mRS = 0). All FRED were patent at follow-up. No early or delayed aneurysm rupture, no subarachnoid (SAH) or intraparenchymal hemorrhage (IPH) no ischemic complications and no deaths occurred. CONCLUSIONS: Endovascular treatment with FRED FDD is a safe treatment for unruptured cerebral aneurysms, resulting in a high rate of occlusion. The FRED is substantially equivalent to the other known FDDs, which show similar functions and technical profiles.
Authors: M A Möhlenbruch; O Kizilkilic; M Killer-Oberpfalzer; F Baltacioglu; C Islak; M Bendszus; S Cekirge; I Saatci; N Kocer Journal: AJNR Am J Neuroradiol Date: 2017-08-10 Impact factor: 3.825
Authors: G Foa Torres; F Roca; A Noguera; J Godes; S Petrocelli; I Aznar; S Ales; P Muszynski; R Maehara; M Vicente; J M Pumar Journal: Interv Neuroradiol Date: 2018-05-02 Impact factor: 1.610
Authors: Pervinder Bhogal; Victoria Hellstern; Hansjörg Bäzner; Oliver Ganslandt; Hans Henkes; Marta Aguilar Pérez Journal: Front Neurol Date: 2017-08-07 Impact factor: 4.003
Authors: P Bhogal; R Martinez Moreno; O Ganslandt; H Bäzner; H Henkes; M Aguilar Perez Journal: J Neurointerv Surg Date: 2016-10-27 Impact factor: 5.836
Authors: Muhammad Waqas; Rimal H Dossani; Modhi Alkhaldi; Jocelyn Neveu; Justin M Cappuzzo; Jaims Lim; Asham Khan; Victoria Lazarov; Andre Monteiro; Jason M Davies; Adnan H Siddiqui; Elad I Levy Journal: Interv Neuroradiol Date: 2021-06-30 Impact factor: 1.764